| 发明名称 |
MOLECULAR MARKERS FOR PROGNOSTICALLY PREDICTING PROSTATE CANCER, METHOD AND KIT THEREOF |
| 摘要 |
The present application provides a method for predicting clinical prognosis for a human subject diagnosed with prostate cancer, comprising: detecting an expression level of a marker gene selected from a group consisting of ABCG1, PDCD4, KLF6, ST6, BTD, BANF1, IRS1, ZNF185, ANXA11, DUSP2, KLF4 and DSC2, in a biological sample containing prostate cancer cells obtained from the human subject; and predicting a likehood of the clinical prognosis by comparing the expression level of the marker gene with a reference level. The present application also provides a combination of molecular markers and a kit containing thereof. |
| 申请公布号 |
US2015191793(A1) |
申请公布日期 |
2015.07.09 |
| 申请号 |
US201414568075 |
申请日期 |
2014.12.11 |
| 申请人 |
NATIONAL HEALTH RESEARCH INSTITUTES |
发明人 |
TSAI Kun-Chih Kelvin;LI Chi-Rong;SU Jiun-Ming Jimmy |
| 分类号 |
C12Q1/68;G01N33/574 |
主分类号 |
C12Q1/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method for predicting clinical prognosis for a human subject diagnosed with prostate cancer, comprising:
detecting an expression level of a marker gene selected from a group consisting of ABCG1, PDCD4, KLF6, ST6, BTD, BANF1, IRS1, ZNF185, ANXA11, DUSP2, KLF4 and DSC2, in a biological sample containing prostate cancer cells obtained from the human subject; and predicting a likelihood of the clinical prognosis by comparing the expression level of the marker gene with a reference level. |
| 地址 |
Miaoli County TW |
